Skip to main content
. Author manuscript; available in PMC: 2020 Jan 3.
Published in final edited form as: Biochemistry. 2019 Aug 26;58(36):3813–3822. doi: 10.1021/acs.biochem.9b00523

Table 2.

Treatment of Clinical Isolates of MRSAa

removing resistance
strain oxacillin MIC (μg/mL) [oxacillin] (μg/mL) [BPEI] (μg/mL) BPEI MIC (μg/mL) FICI
1 256 2 16 32 0.508
2 8 2 1 32 0.281
3 64 2 16 16 1.03
4 64 2 8 32 0.281
5 128 2 16 64 0.266
6 32 2 8 64 0.188
7 128 2 16 64 0.266
8 256 2 8 8 1.01
9 32 2 16 64 0.313
10 16 2 32 256 0.25
11 256 2 32 64 0.508
12 64 2 32 128 0.281
13 16 2 4 8 0.625
14 32 2 8 64 0.188
15 16 2 2 256 0.133
16 32 2 2 256 0.125
a

Data show the concentration of BPEI required to reduce the MIC of oxacillin to the susceptibility cutoff of 2 μg/mL. Each value is the average of four trials.